ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

MAX HEMPING PHYSICIANS ASSISTANT

At A Glance: This Prescriber in 2012

Physician Assistant

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,201Medicare Part D Prescriptions Filled, Including Refills

Rank: 9 out of 1188

$670K Total Retail Price of All Prescriptions

Rank: 18 out of 1188

394 Patients Receiving at Least One Drug in Part D
43%Patients 65 Years and Older
95% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

42% of this provider’s 394 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Risky Drugs to Seniors

3% of this provider’s 4,607 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 8.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
HYDROCODONE-ACETAMINOPHEN 1,418 583 S3 1 1
OMEPRAZOLE 275 153 2 5
LEVOTHYROXINE SODIUM 270 150 3 7
AMLODIPINE BESYLATE 249 109 4 6
FUROSEMIDE 211 155 5 12
GABAPENTIN 186 72 6 9
ZOLPIDEM TARTRATE 167 62 7 17
CYMBALTA 146 80 8 56
POTASSIUM CHLORIDE 141 91 9 63
SIMVASTATIN 135 79 10 2
NEXIUM 131 66 11 71
METFORMIN HCL ER 128 34 12 127
ENALAPRIL MALEATE 125 83 13 58
CARISOPRODOL 123 32 R 14 19
LISINOPRIL 123 57 14 3
BACLOFEN 120 0 16 55
IBUPROFEN 119 39 17 13
FLUOXETINE HCL 114 49 18 57
CRESTOR 102 11 19 45
CIMETIDINE 101 23 20 284
SINGULAIR 101 43 20 100
VENTOLIN HFA 98 48 22 108
SPIRIVA 96 39 23 77
ADVAIR DISKUS 96 32 23 53
GLYBURIDE 89 52 R 25 85
ESCITALOPRAM OXALATE 88 35 26 152
METFORMIN HCL 85 42 27 4
TRAZODONE HCL 83 31 28 63
PROAIR HFA 82 45 29 33
NITROSTAT 81 43 30 144
CARVEDILOL 81 57 30 22
LANTUS 79 56 32 52
PREMARIN 78 35 R 33 182
RAMIPRIL 76 31 34 146
CITALOPRAM HBR 75 41 35 44
TRAMADOL HCL 74 29 36 16
METOPROLOL TARTRATE 71 44 37 24
ABILIFY 70 23 38 103
CLONIDINE HCL 65 50 39 107
FLUTICASONE PROPIONATE 65 32 39 41
AZITHROMYCIN 65 25 39 35
DEXILANT 63 45 42 90
MONTELUKAST SODIUM 62 25 43 202
XOPENEX HFA 60 17 44 223
BENAZEPRIL HCL 60 34 44 15
VENLAFAXINE HCL ER 59 25 46 160
NAPROXEN 58 21 47 38
TAMSULOSIN HCL 57 35 48 26
ATENOLOL 57 21 48 14
HYDROCHLOROTHIAZIDE 56 24 50 8
DIOVAN 55 30 51 31
WARFARIN SODIUM 54 48 52 25
GLIMEPIRIDE 52 24 53 34
BUPROPION XL 52 20 53 170
CIPROFLOXACIN HCL 51 19 55 42
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 17, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.